JP2010514786A5 - - Google Patents

Download PDF

Info

Publication number
JP2010514786A5
JP2010514786A5 JP2009544215A JP2009544215A JP2010514786A5 JP 2010514786 A5 JP2010514786 A5 JP 2010514786A5 JP 2009544215 A JP2009544215 A JP 2009544215A JP 2009544215 A JP2009544215 A JP 2009544215A JP 2010514786 A5 JP2010514786 A5 JP 2010514786A5
Authority
JP
Japan
Prior art keywords
group
aryl
alkyl
heteroaryl
nhr
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2009544215A
Other languages
English (en)
Japanese (ja)
Other versions
JP5656408B2 (ja
JP2010514786A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2007/088500 external-priority patent/WO2008083056A2/en
Publication of JP2010514786A publication Critical patent/JP2010514786A/ja
Publication of JP2010514786A5 publication Critical patent/JP2010514786A5/ja
Application granted granted Critical
Publication of JP5656408B2 publication Critical patent/JP5656408B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2009544215A 2006-12-26 2007-12-21 心臓の神経支配を画像化するためのリガンド Active JP5656408B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US87721106P 2006-12-26 2006-12-26
US60/877,211 2006-12-26
PCT/US2007/088500 WO2008083056A2 (en) 2006-12-26 2007-12-21 Ligands for imaging cardiac innervation

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2014152244A Division JP6021860B2 (ja) 2006-12-26 2014-07-25 心臓の神経支配を画像化するためのリガンド

Publications (3)

Publication Number Publication Date
JP2010514786A JP2010514786A (ja) 2010-05-06
JP2010514786A5 true JP2010514786A5 (enExample) 2011-02-24
JP5656408B2 JP5656408B2 (ja) 2015-01-21

Family

ID=39307501

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2009544215A Active JP5656408B2 (ja) 2006-12-26 2007-12-21 心臓の神経支配を画像化するためのリガンド
JP2014152244A Active JP6021860B2 (ja) 2006-12-26 2014-07-25 心臓の神経支配を画像化するためのリガンド
JP2016085372A Pending JP2016183164A (ja) 2006-12-26 2016-04-21 心臓の神経支配を画像化するためのリガンド

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2014152244A Active JP6021860B2 (ja) 2006-12-26 2014-07-25 心臓の神経支配を画像化するためのリガンド
JP2016085372A Pending JP2016183164A (ja) 2006-12-26 2016-04-21 心臓の神経支配を画像化するためのリガンド

Country Status (20)

Country Link
US (5) US8491868B2 (enExample)
EP (5) EP2474523B1 (enExample)
JP (3) JP5656408B2 (enExample)
KR (4) KR101810348B1 (enExample)
CN (3) CN105622463B (enExample)
AU (1) AU2007339954B2 (enExample)
BR (1) BRPI0722082A8 (enExample)
CA (2) CA2984226C (enExample)
CO (1) CO6231002A2 (enExample)
DK (3) DK2474523T3 (enExample)
ES (3) ES2804801T3 (enExample)
IL (3) IL199563A (enExample)
MX (2) MX2009007018A (enExample)
PL (1) PL2114873T3 (enExample)
PT (1) PT2114873E (enExample)
RU (1) RU2506256C2 (enExample)
SG (1) SG177918A1 (enExample)
TW (2) TWI618544B (enExample)
WO (1) WO2008083056A2 (enExample)
ZA (1) ZA200904828B (enExample)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7344702B2 (en) 2004-02-13 2008-03-18 Bristol-Myers Squibb Pharma Company Contrast agents for myocardial perfusion imaging
EP2474523B1 (en) * 2006-12-26 2020-04-08 Lantheus Medical Imaging, Inc. Ligands for imaging cardiac innervation
RU2631500C2 (ru) 2010-02-08 2017-09-25 Лантеус Медикал Имаджинг, Инк. Способы и устройство для синтезирования радиофармацевтических препаратов и их промежуточных продуктов
MX343721B (es) * 2010-05-11 2016-11-17 Lantheus Medical Imaging Inc Composiciones, metodos y sistemas para la sintesis y el uso de agentes trazadores.
MX384074B (es) 2010-05-14 2025-03-12 Dana Farber Cancer Inst Inc Composiciones y métodos para tratar neoplasias, enfermedades inflamatorias y otros trastornos.
US9301962B2 (en) 2010-05-14 2016-04-05 Baylor College Of Medicine Male contraceptive compositions and methods of use
MX373121B (es) * 2010-05-14 2020-04-30 Dana Farber Cancer Inst Inc Composiciones y metodos para el tratamiento de leucemia.
AR086113A1 (es) 2011-04-30 2013-11-20 Abbott Lab Isoxazolinas como agentes terapeuticos
US9550000B2 (en) * 2011-09-09 2017-01-24 Lantheus Medical Imaging, Inc. Compositions, methods, and systems for the synthesis and use of imaging agents
WO2013173004A2 (en) 2012-04-10 2013-11-21 Lantheus Medical Imaging, Inc. Radiopharmaceutical synthesis methods
AU2013203000B9 (en) 2012-08-10 2017-02-02 Lantheus Medical Imaging, Inc. Compositions, methods, and systems for the synthesis and use of imaging agents
US20150246142A1 (en) * 2012-09-25 2015-09-03 The Regents Of The University Of Michigan Imaging agents
JP6470185B2 (ja) 2013-01-24 2019-02-13 タイラートン インターナショナル ホールディングス インコーポレイテッドＴｙｌｅｒｔｏｎ Ｉｎｔｅｒｎａｔｉｏｎａｌ Ｈｏｌｄｉｎｇｓ Ｉｎｃ． 身体構造イメージング
AU2014208383A1 (en) 2013-01-24 2015-07-23 Tylerton International Holdings Inc. Neuronal imaging and treatment
CN105163657A (zh) * 2013-03-11 2015-12-16 泰勒顿国际控股公司 自主神经系统建模及其用途
WO2015013635A2 (en) 2013-07-25 2015-01-29 Dana-Farber Cancer Institute, Inc. Inhibitors of transcription factors and uses thereof
WO2015033317A2 (en) * 2013-09-08 2015-03-12 Shlomo Ben-Haim Detection of reduced-control cardiac zones
EP3066101B1 (en) 2013-11-08 2020-07-29 Dana-Farber Cancer Institute, Inc. Combination therapy for cancer using bromodomain and extra-terminal (bet) protein inhibitors
CN106102583B (zh) 2014-01-10 2024-08-09 泰勒顿国际控股公司 瘢痕和纤维心脏区的检测
WO2015117087A1 (en) 2014-01-31 2015-08-06 Dana-Farber Cancer Institute, Inc. Uses of diazepane derivatives
EP3099677A4 (en) 2014-01-31 2017-07-26 Dana-Farber Cancer Institute, Inc. Diaminopyrimidine benzenesulfone derivatives and uses thereof
KR20160130778A (ko) 2014-02-28 2016-11-14 텐샤 세러퓨틱스 인코포레이티드 고인슐린혈증과 관련된 질환의 치료
US10776961B2 (en) 2014-07-30 2020-09-15 Navix International Limited Registering nuclear medicine data
EP3177626A4 (en) 2014-08-08 2017-12-27 Dana Farber Cancer Institute, Inc. Diazepane derivatives and uses thereof
MX2017001757A (es) 2014-08-08 2017-05-30 Dana Farber Cancer Inst Inc Derivados de dihidropteridinona y sus usos.
EP3307728A4 (en) 2015-06-12 2019-07-17 Dana Farber Cancer Institute, Inc. COMBINATION THERAPY OF TRANSCRIPTION INHIBITORS AND CHINESE INHIBITORS
PE20181287A1 (es) 2015-09-11 2018-08-07 Dana Farber Cancer Inst Inc Ciano tienotriazolpirazinas y usos de las mismas
UA123946C2 (uk) 2015-09-11 2021-06-30 Дана-Фарбер Кенсер Інстітьют, Інк. Ацетамідтієнотриазолодіазепіни й шляхи їх застосування
CA3003288A1 (en) 2015-11-25 2017-06-01 Dana-Farber Cancer Institute, Inc. Bivalent bromodomain inhibitors and uses thereof
CN107892651A (zh) * 2017-11-29 2018-04-10 陕西慧康生物科技有限责任公司 一种合成dl‑盐酸麻黄碱的方法
US20210379210A1 (en) * 2018-10-15 2021-12-09 Bristol-Myers Squibb Company Radioligands for imaging the lpa1 receptor
EP3682906A1 (en) 2019-01-17 2020-07-22 Julius-Maximilians-Universität Würzburg Compound targeting norepinephrine transporter
CN109748825B (zh) * 2019-02-01 2022-02-18 原子高科股份有限公司 一种18f标记的胍甲基取代苯类似物及其应用
KR102690858B1 (ko) 2020-07-14 2024-08-02 한국과학기술원 이산화탄소와 개미산만으로 성장 가능한 재조합 미생물 및 상기 재조합 미생물을 이용하여 유용물질을 제조하는 방법
WO2025244832A1 (en) * 2024-05-21 2025-11-27 Kong's Pharmaceutical Co. Novel aminoguanidine derivatives, and compositions and methods thereof

Family Cites Families (76)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6012A (en) * 1849-01-09 Lithographing co
FR1010218A (fr) 1949-02-10 1952-06-09 American Cyanamid Co Perfectionnements aux sels de guanidine
GB1215255A (en) 1968-03-13 1970-12-09 Pfizer & Co C Halophenylalkylguanidine compounds
US4094881A (en) * 1976-03-10 1978-06-13 Smithkline Corporation Process for preparing triazolethiols
US4275074A (en) 1979-03-09 1981-06-23 Graham J. Dobbie Catecholamine treatment of ocular hypertension
US4270537A (en) * 1979-11-19 1981-06-02 Romaine Richard A Automatic hypodermic syringe
US4258188A (en) * 1980-02-04 1981-03-24 American Home Products Corporation 2-(1-Piperazinyl)-cycloheptimidazole derivatives
US4622217A (en) * 1984-04-27 1986-11-11 The Regents Of The University Of Michigan I-4-amino-3-iodobenzylguanidine as imaging and therapeutic agent
US4596556A (en) * 1985-03-25 1986-06-24 Bioject, Inc. Hypodermic injection apparatus
US4886499A (en) * 1986-12-18 1989-12-12 Hoffmann-La Roche Inc. Portable injection appliance
GB8704027D0 (en) * 1987-02-20 1987-03-25 Owen Mumford Ltd Syringe needle combination
EP0288284A3 (en) * 1987-04-24 1990-07-25 King Faisal Specialist Hospital And Research Centre Method of producing iodine 124 and meta-iodobenzylguanidine containing iodine 124
US4940460A (en) * 1987-06-19 1990-07-10 Bioject, Inc. Patient-fillable and non-invasive hypodermic injection device assembly
US4790824A (en) * 1987-06-19 1988-12-13 Bioject, Inc. Non-invasive hypodermic injection device
US4941880A (en) * 1987-06-19 1990-07-17 Bioject, Inc. Pre-filled ampule and non-invasive hypodermic injection device assembly
US5339163A (en) * 1988-03-16 1994-08-16 Canon Kabushiki Kaisha Automatic exposure control device using plural image plane detection areas
FR2638359A1 (fr) * 1988-11-03 1990-05-04 Tino Dalto Guide de seringue avec reglage de la profondeur de penetration de l'aiguille dans la peau
US5064413A (en) * 1989-11-09 1991-11-12 Bioject, Inc. Needleless hypodermic injection device
US5312335A (en) * 1989-11-09 1994-05-17 Bioject Inc. Needleless hypodermic injection device
US5190521A (en) * 1990-08-22 1993-03-02 Tecnol Medical Products, Inc. Apparatus and method for raising a skin wheal and anesthetizing skin
US5527288A (en) * 1990-12-13 1996-06-18 Elan Medical Technologies Limited Intradermal drug delivery device and method for intradermal delivery of drugs
GB9118204D0 (en) * 1991-08-23 1991-10-09 Weston Terence E Needle-less injector
SE9102652D0 (sv) * 1991-09-13 1991-09-13 Kabi Pharmacia Ab Injection needle arrangement
US5663166A (en) * 1991-10-18 1997-09-02 Genentech, Inc. Nonpeptidyl integrin inhibitors having specificity for the GPIIb IIIa receptor
US5328483A (en) * 1992-02-27 1994-07-12 Jacoby Richard M Intradermal injection device with medication and needle guard
US5383851A (en) * 1992-07-24 1995-01-24 Bioject Inc. Needleless hypodermic injection device
US5569189A (en) * 1992-09-28 1996-10-29 Equidyne Systems, Inc. hypodermic jet injector
US5334144A (en) * 1992-10-30 1994-08-02 Becton, Dickinson And Company Single use disposable needleless injector
TW279864B (enExample) * 1993-02-19 1996-07-01 Janssen Pharmaceutica Nv
US5879657A (en) * 1993-03-30 1999-03-09 The Dupont Merck Pharmaceutical Company Radiolabeled platelet GPIIb/IIIa receptor antagonists as imaging agents for the diagnosis of thromboembolic disorders
EP0639573A1 (de) * 1993-08-03 1995-02-22 Hoechst Aktiengesellschaft Benzokondensierte 5-Ringheterocyclen, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament, ihre Verwendung als Diagnostikum, sowie sie enthaltendes Medikament
WO1995024176A1 (en) * 1994-03-07 1995-09-14 Bioject, Inc. Ampule filling device
US5466220A (en) * 1994-03-08 1995-11-14 Bioject, Inc. Drug vial mixing and transfer device
US5599302A (en) * 1995-01-09 1997-02-04 Medi-Ject Corporation Medical injection system and method, gas spring thereof and launching device using gas spring
US5730723A (en) 1995-10-10 1998-03-24 Visionary Medical Products Corporation, Inc. Gas pressured needle-less injection device and method
WO1997001360A2 (en) * 1995-06-26 1997-01-16 Concat, Ltd. Compounds with chelation affinity and selectivity for first transition series elements and their use in medical therapy and diagnosis
US5893397A (en) * 1996-01-12 1999-04-13 Bioject Inc. Medication vial/syringe liquid-transfer apparatus
GB9607549D0 (en) 1996-04-11 1996-06-12 Weston Medical Ltd Spring-powered dispensing device
TW499412B (en) 1996-11-26 2002-08-21 Dimensional Pharm Inc Aminoguanidines and alkoxyguanidines as protease inhibitors
WO1998023608A1 (en) 1996-11-27 1998-06-04 Dupont Pharmaceuticals Company Novel integrin receptor antagonists
US5993412A (en) * 1997-05-19 1999-11-30 Bioject, Inc. Injection apparatus
CA2345710C (en) * 1997-10-02 2008-12-30 The University Of Western Ontario Preparation of radiolabelled haloaromatics via polymer-bound intermediates
IT1298087B1 (it) 1998-01-08 1999-12-20 Fiderm S R L Dispositivo per il controllo della profondita' di penetrazione di un ago, in particolare applicabile ad una siringa per iniezioni
AU3406599A (en) 1998-04-09 1999-11-01 Institut Fur Diagnostikforschung Gmbh An Der Freien Universitat Berlin Novel benzyl guanidine derivatives for therapy and (in-vivo) and (in-vitro) diagnosis
WO2000009115A1 (en) 1998-08-14 2000-02-24 Smithkline Beecham Corporation Grp receptor ligands
CA2349501A1 (en) * 1998-12-18 2000-06-22 Du Pont Pharmaceuticals Company Quinolone vitronectin receptor antagonist pharmaceuticals
US6656448B1 (en) 2000-02-15 2003-12-02 Bristol-Myers Squibb Pharma Company Matrix metalloproteinase inhibitors
GB0019357D0 (en) 2000-08-07 2000-09-27 Melacure Therapeutics Ab Novel phenyl guanidines
DE10114561A1 (de) 2001-03-24 2002-09-26 Wella Ag Verwendung von Mitteln enthaltend Kreatin, Kreatin und/oder deren Derivaten zur Verstärkung und Strukturverbesserung von keratinischen Fasern
US7344702B2 (en) 2004-02-13 2008-03-18 Bristol-Myers Squibb Pharma Company Contrast agents for myocardial perfusion imaging
AU2003263216A1 (en) 2002-08-17 2004-03-11 Nycomed Gmbh Benzonaphthyridines with PDE 3/4 inhibiting activity
WO2004037166A2 (en) 2002-09-17 2004-05-06 Isis Pharmaceuticals, Inc. Therapeutic guanidines
US7754188B2 (en) 2003-06-30 2010-07-13 Merck Sharp & Dohme Corp. Radiolabeled cannabinoid-1 receptor modulators
AU2004294989B2 (en) * 2003-12-01 2009-03-19 Ignasi Carrio Novel differential imaging method
WO2005095345A2 (en) * 2004-03-23 2005-10-13 Achillion Pharmaceuticals, Inc. Heteroaryl guanidines as inhibitors of viral replication
EP1749815B1 (en) * 2004-05-28 2017-06-21 Hamamatsu Photonics K.K. Radioactive tyrosine derivative, method for producing same, labeling agent for positron imaging and medical agent for assessing grade of malignancy of tumor respectively composed of radioactive tyrosine derivative, and method for detecting tumor
JP2008513533A (ja) 2004-09-23 2008-05-01 ゲルベ Ｃｅｓｔイメージング用の造影剤封入システム
US20060083681A1 (en) * 2004-10-18 2006-04-20 Ajay Purohit Compounds for myocardial perfusion imaging
US7534418B2 (en) * 2004-12-10 2009-05-19 The Regents Of The University Of Michigan Imaging agents
GB0512770D0 (en) 2005-06-23 2005-07-27 Hammersmith Imanet Ltd Imaging compounds
KR101189348B1 (ko) * 2006-12-13 2012-10-09 에프. 호프만-라 로슈 아게 미량 아민 결합 수용체(ｔａａｒ)에 대한 리간드로서의 신규한 2-이미다졸
GB0625523D0 (en) 2006-12-21 2007-01-31 Ge Healthcare Ltd In vivo imaging agents
EP2474523B1 (en) 2006-12-26 2020-04-08 Lantheus Medical Imaging, Inc. Ligands for imaging cardiac innervation
WO2008082305A1 (en) 2006-12-28 2008-07-10 Raufoss Technology As Control arm
EP2139481B1 (en) 2007-03-21 2013-08-21 The University Of Montana 1-[(2'-substituted)-piperazin-1'-yl]-isoquinolines as norepinephrine transporter inhibitor therapeutics and positron emission tomography imaging agents
MX2010003826A (es) 2007-10-18 2010-04-21 Boehringer Ingelheim Int Preparacion de dihidrotieno [3,2-d] pirimidinas e intermedios usados en la misma.
WO2010015340A1 (en) 2008-08-06 2010-02-11 Bayer Schering Pharma Aktiengesellschaft Daa-pyridine as peripheral benzodiazepine receptor ligand for diagnostic imaging and pharmaceutical treatment
GB0906274D0 (en) 2009-04-09 2009-05-20 Ge Healthcare Ltd Imaging the central nervous system
ES2770364T3 (es) 2009-04-15 2020-07-01 Lantheus Medical Imaging Inc Estabilización de composiciones radiofarmacéuticas utilizando ácido ascórbico
CN101555232B (zh) 2009-05-21 2011-01-05 北京师范大学 氟-18标记哒嗪酮类化合物及制备方法和应用
EP2451776B1 (en) 2009-07-08 2019-09-18 Lantheus Medical Imaging, Inc. N-alkoxyamide conjugates as imaging agents
RU2631500C2 (ru) 2010-02-08 2017-09-25 Лантеус Медикал Имаджинг, Инк. Способы и устройство для синтезирования радиофармацевтических препаратов и их промежуточных продуктов
MX343721B (es) 2010-05-11 2016-11-17 Lantheus Medical Imaging Inc Composiciones, metodos y sistemas para la sintesis y el uso de agentes trazadores.
US9550000B2 (en) 2011-09-09 2017-01-24 Lantheus Medical Imaging, Inc. Compositions, methods, and systems for the synthesis and use of imaging agents
EP2671575A1 (en) 2012-06-04 2013-12-11 Universität Regensburg Ras inhibitors
JP2017131851A (ja) 2016-01-29 2017-08-03 日本特殊陶業株式会社 マイクロ波加熱用触媒材料、マイクロ波加熱用触媒体、及び、その製造方法

Similar Documents

Publication Publication Date Title
RU2468029C2 (ru) Ингибиторы hcv ns3 протеазы
RU2325381C2 (ru) Замещенные гетероциклические производные и их применение
JP2004516314A5 (enExample)
HRP20200549T1 (hr) Određeni amino-pirimidini, njihovi sastavi, i metode njihove upotrebe
RU2009128591A (ru) Лиганды для визуализации иннервации сердца
JP2012505871A5 (enExample)
JP2003519676A5 (enExample)
JP2012502048A5 (enExample)
JP2002543185A5 (enExample)
JP2016518434A5 (enExample)
JP2005539088A5 (enExample)
JP2007504171A5 (enExample)
JP2002543183A5 (enExample)
JP2011137006A5 (enExample)
JP2013528180A5 (enExample)
RU2008152087A (ru) Макроциклические оксимильные ингибиторы протеазы гепатита
JP2010513441A5 (enExample)
JP2004530641A5 (enExample)
JP2002540208A5 (enExample)
JP2010527913A5 (enExample)
JP2008533191A5 (enExample)
JP2009535358A5 (enExample)
JP2010510171A5 (enExample)
JP2008505157A5 (enExample)
JP2007534702A5 (enExample)